In just a few short years, the tobacco giant has established itself as an income producer.
GlaxoSmithKline is yielding nearly 6% on a trailing 12-month basis, but these three factors have the potential to dramatically cut its payout in the coming years.
There are few things that are more disappointing for investors than an unsustainable dividend. Income investors in these three healthcare stocks could be headed for disappointment.
A look into two diversified REITs to follow.
Last week's distribution lifters included a pair of well-known companies and a scrappy convenience store operator.
A double-digit dividend yield can be alluring to investors, but it can also be dangerous if it's not sustainable. According to three of our top analysts, these three high-yield dividend stocks could be headed for a cut.
This much-hated tax form has gotten a lot more common lately.
Two mortgage REITs I think high-yield investors should watch.
Understanding the ex-dividend date can prevent a lot of confusion later on.
In looking for income investments, preferred stock can be a good choice.